APOLD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.242200E-01
Normal-vs-Stage2
3.529400E-01
Normal-vs-Stage3
3.982000E-01
Normal-vs-Stage4
3.564200E-01
Stage1-vs-Stage2
4.700400E-01
Stage1-vs-Stage3
3.884600E-01
Stage1-vs-Stage4
7.085000E-01
Stage2-vs-Stage3
6.530800E-01
Stage2-vs-Stage4
9.263000E-01
Stage3-vs-Stage4
6.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.128600E-01
Normal-vs-AfricanAmerican
2.796000E-01
Normal-vs-Asian
8.809600E-01
Caucasian-vs-AfricanAmerican
7.682400E-01
Caucasian-vs-Asian
5.243100E-03
AfricanAmerican-vs-Asian
1.791810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.153800E-01
Normal-vs-Female
3.206500E-04
Male-vs-Female
2.641800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.844170E-01
Normal-vs-Age(41-60Yrs)
2.580100E-04
Normal-vs-Age(61-80Yrs)
3.927400E-01
Normal-vs-Age(81-100Yrs)
4.338600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.818000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.153200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.396200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.343600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.162400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.497400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.464400E-01
Normal-vs-Daily Drinker
8.093600E-02
Normal-vs-Weekly Drinker
5.992600E-01
Normal-vs-Occasional Drinker
2.937400E-01
Normal-vs-Social Drinker
1.462640E-01
Non Drinker-vs-Daily Drinker
9.070400E-01
Non Drinker-vs-Weekly Drinker
3.235600E-01
Non Drinker-vs-Occasional Drinker
8.605200E-01
Non Drinker-vs-Social Drinker
6.787600E-01
Daily Drinker-vs-Weekly Drinker
3.601600E-01
Daily Drinker-vs-Occasional Drinker
9.754200E-01
Daily Drinker-vs-Social Drinker
7.410600E-01
Weekly Drinker-vs-Occasional Drinker
2.698400E-01
Weekly Drinker-vs-Social Drinker
3.410400E-01
Occasional Drinker-vs-Social Drinker
7.570400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.157000E-01
Normal-vs-Grade 2
6.463600E-01
Normal-vs-Grade 3
8.524400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.869800E-01
Grade 1-vs-Grade 3
4.712400E-01
Grade 1-vs-Grade 4
7.157000E-01
Grade 2-vs-Grade 3
1.819400E-01
Grade 2-vs-Grade 4
6.463600E-01
Grade 3-vs-Grade 4
8.524400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.360800E-01
Normal-vs-NonDiabetic
3.733800E-01
Diabetic-vs-NonDiabetic
9.461000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.298400E-01
Normal-vs-NoPancreatitis
3.391200E-01
Pancreatitis-vs-NoPancreatitis
2.710800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.014000E-01
Normal-vs-N1
3.149800E-01
N0-vs-N1
6.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.959400E-01
Normal-vs-TP53-NonMutant
8.399600E-01
TP53-Mutant-vs-TP53-NonMutant
1.561970E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
